Your browser doesn't support javascript.
Re: Remdesivir for the treatment of COVID-19 by Lee et al.
Beccacece, Alessia; Ascoli Bartoli, Tommaso; Nicastri, Emanuele.
  • Beccacece A; National Institute for Infectious Diseases Lazzaro, Spallanzani Institute for Hospitalization and Care Scientific, Clinical, Division of Infectious Diseases, Italy. Electronic address: alessia.beccacece@inmi.it.
  • Ascoli Bartoli T; National Institute for Infectious Diseases, Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Clinical Department, Italy.
  • Nicastri E; National Institute for Infectious Diseases, Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Clinical Department, Italy; INMI "L. Spallanzani", Clinical Department, Italy.
Clin Microbiol Infect ; 2022 Oct 04.
Article in English | MEDLINE | ID: covidwho-2239068
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article